Skip to main content

The Injury Prevention Program Reduces Parent-Reported Injuries in Children

Medically reviewed by Carmen Pope, BPharm. Last updated on April 1, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, April 1, 2024 -- Implementation of The Injury Prevention Program (TIPP), designed by the American Academy of Pediatrics, results in a reduction in parent-reported injuries at well-child checks (WCCs), according to a study published online April 1 in Pediatrics.

Eliana M. Perrin, M.D., M.P.H., from the Johns Hopkins University Schools of Medicine and Nursing in Baltimore, and colleagues conducted a stratified, cluster randomized trial at four academic medical centers. Two centers implemented TIPP screening and counselling materials at WCCs for ages 2 to 24 months and two centers implemented obesity prevention. Parents reported the number of child injuries since the previous WCC at each WCC. A total of 781 parent-infant dyads were enrolled: 349 in the TIPP group and 432 in the control group; 51 and 28 percent were Hispanic and non-Hispanic Black, respectively, and 87 percent were insured by Medicaid.

The researchers found that throughout follow-up, the adjusted odds of reporting injuries were significantly reduced at TIPP sites versus non-TIPP sites, with adjusted odds ratios of 0.77, 0.60, 0.32, 0.26, and 0.27 at four, six, 12, 18, and 24 months, respectively.

"Although further research is needed to determine if TIPP prevents serious injuries and prevents injuries in nontraining settings, our study provides important evidence that a primary care-based intervention can be effective in reducing injury," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care

TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.